Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
DEPT OF DEFENSE
Free. Verify your email, then we send one reminder only.
- Posted
- Aug 18, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBSame funderOpenDEPT OF DEFENSECloses Jan 2031
- JPEO-CBRND CWMD BOTAA-24-01Same funderOpenDEPT OF DEFENSECloses Feb 2029
- Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersSame funderOpenDEPT OF DEFENSECloses Oct 2028
At a glance
This is a government contract opportunity posted by DEPT OF DEFENSE in the research and development in biotechnology (except nanobiotechnology) category.
Classification and identifiers
- Industry (NAICS)
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- Product or service (PSC)
- National Defense R&D Services; Department of Defense - Military; Experimental Development (AC13)
- Solicitation number
- W911SR-26-R-HEAL
- Contracting office
- W6QK ACC-APG
Who can apply
About this opportunity
This is a continuous, open announcement with no deadline unless specifically noted. (Please note this posting was formerly the Threat Agnostic Host-Directed Therapeutics/HEALER PBA. If a white paper was previously submitted under the HEALER name, then the submission is still valid for the revised annoucement.) 1. Strategic Opportunity: The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) invites interested parties to enter into the CBRN Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This PBA establishes a unified, open, and continuous network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation CBRN medical defense solutions. The goal is to create streamlined, framewo...
Related opportunities
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBSame funderDEPT OF DEFENSECloses Jan 2031
- JPEO-CBRND CWMD BOTAA-24-01Same funderDEPT OF DEFENSECloses Feb 2029
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBSame funderDEPT OF DEFENSECloses Jun 2027
- Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersSame funderDEPT OF DEFENSECloses Oct 2028